145 related articles for article (PubMed ID: 34680117)
1. Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies.
Campo MD; Pijnenburg YAL; Chen-Plotkin A; Irwin DJ; Grossman M; Twaalfhoven HAM; Hu WT; Meeter LH; van Swieten J; Vermunt L; Martens F; Heijboer AC; Teunissen CE
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680117
[TBL] [Abstract][Full Text] [Related]
2. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
[TBL] [Abstract][Full Text] [Related]
3. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
[TBL] [Abstract][Full Text] [Related]
4. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
[TBL] [Abstract][Full Text] [Related]
5. Novel CSF biomarkers for frontotemporal lobar degenerations.
Hu WT; Chen-Plotkin A; Grossman M; Arnold SE; Clark CM; Shaw LM; McCluskey L; Elman L; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
Neurology; 2010 Dec; 75(23):2079-86. PubMed ID: 21048198
[TBL] [Abstract][Full Text] [Related]
6. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
[TBL] [Abstract][Full Text] [Related]
8. Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
Alcolea D; Irwin DJ; Illán-Gala I; Muñoz L; Clarimón J; McMillan CT; Fortea J; Blesa R; Lee EB; Trojanowski JQ; Grossman M; Lleó A
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):180-186. PubMed ID: 30297518
[TBL] [Abstract][Full Text] [Related]
9. Novel CSF biomarkers to discriminate FTLD and its pathological subtypes.
Del Campo M; Galimberti D; Elias N; Boonkamp L; Pijnenburg YA; van Swieten JC; Watts K; Paciotti S; Beccari T; Hu W; Teunissen CE
Ann Clin Transl Neurol; 2018 Oct; 5(10):1163-1175. PubMed ID: 30349851
[TBL] [Abstract][Full Text] [Related]
10. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.
Hu WT; Watts K; Grossman M; Glass J; Lah JJ; Hales C; Shelnutt M; Van Deerlin V; Trojanowski JQ; Levey AI
Neurology; 2013 Nov; 81(22):1945-52. PubMed ID: 24174584
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
[TBL] [Abstract][Full Text] [Related]
12. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
[TBL] [Abstract][Full Text] [Related]
13. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.
Borroni B; Benussi A; Archetti S; Galimberti D; Parnetti L; Nacmias B; Sorbi S; Scarpini E; Padovani A
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):86-91. PubMed ID: 25352065
[TBL] [Abstract][Full Text] [Related]
14. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.
Pijnenburg YA; Verwey NA; van der Flier WM; Scheltens P; Teunissen CE
Alzheimers Dement (Amst); 2015 Dec; 1(4):505-12. PubMed ID: 27239528
[TBL] [Abstract][Full Text] [Related]
15. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]